Enovis Price to Free Cash Flow Ratio 2010-2025 | ENOV
Enovis Price to Free Cash Flow Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
2025-05-23 | 31.56 | 0.00 | |
2025-03-31 | 38.21 | $-0.67 | 0.00 |
2024-12-31 | 43.88 | $-1.22 | 0.00 |
2024-09-30 | 43.05 | $-1.28 | 0.00 |
2024-06-30 | 45.20 | $-0.50 | 0.00 |
2024-03-31 | 62.45 | $-0.08 | 0.00 |
2023-12-31 | 56.02 | $0.83 | 67.34 |
2023-09-30 | 52.73 | $-1.08 | 0.00 |
2023-06-30 | 64.12 | $-1.97 | 0.00 |
2023-03-31 | 53.49 | $-2.69 | 0.00 |
2022-12-31 | 53.52 | $-2.93 | 0.00 |
2022-09-30 | 46.07 | $-0.09 | 0.00 |
2022-06-30 | 55.00 | $1.15 | 47.82 |
2022-03-31 | 68.44 | $3.13 | 21.85 |
2021-12-31 | 79.06 | $5.06 | 15.62 |
2021-09-30 | 78.94 | $5.79 | 13.64 |
2021-06-30 | 78.79 | $5.63 | 13.99 |
2021-03-31 | 75.35 | $5.01 | 15.03 |
2020-12-31 | 65.77 | $4.31 | 15.24 |
2020-09-30 | 53.94 | $2.98 | 18.08 |
2020-06-30 | 47.99 | $2.44 | 19.65 |
2020-03-31 | 34.05 | $3.00 | 11.35 |
2019-12-31 | 62.57 | $0.29 | 213.84 |
2019-09-30 | 49.98 | $2.18 | 22.93 |
2019-06-30 | 48.21 | $3.08 | 15.64 |
2019-03-31 | 51.05 | $2.73 | 18.68 |
2018-12-31 | 35.95 | $4.76 | 7.56 |
2018-09-30 | 62.02 | $3.85 | 16.10 |
2018-06-30 | 52.72 | $2.98 | 17.70 |
2018-03-31 | 54.87 | $3.33 | 16.46 |
2017-12-31 | 68.14 | $4.14 | 16.45 |
2017-09-30 | 71.62 | $5.46 | 13.12 |
2017-06-30 | 67.71 | $5.63 | 12.02 |
2017-03-31 | 67.52 | $5.34 | 12.64 |
2016-12-31 | 61.80 | $4.65 | 13.29 |
2016-09-30 | 54.06 | $4.22 | 12.80 |
2016-06-30 | 45.51 | $5.21 | 8.73 |
2016-03-31 | 49.17 | $5.94 | 8.28 |
2015-12-31 | 40.16 | $5.62 | 7.14 |
2015-09-30 | 51.44 | $6.83 | 7.54 |
2015-06-30 | 79.37 | $8.66 | 9.17 |
2015-03-31 | 82.09 | $9.15 | 8.98 |
2014-12-31 | 88.70 | $7.37 | 12.04 |
2014-09-30 | 97.98 | $8.56 | 11.44 |
2014-06-30 | 128.20 | $7.22 | 17.75 |
2014-03-31 | 122.68 | $7.59 | 16.17 |
2013-12-31 | 109.54 | $8.69 | 12.61 |
2013-09-30 | 97.16 | $8.09 | 12.01 |
2013-06-30 | 89.62 | $6.62 | 13.54 |
2013-03-31 | 80.04 | $6.70 | 11.95 |
2012-12-31 | 69.40 | $2.99 | 23.19 |
2012-09-30 | 63.07 | $-0.70 | 0.00 |
2012-06-30 | 47.42 | $-0.83 | 0.00 |
2012-03-31 | 60.61 | $-1.86 | 0.00 |
2011-12-31 | 48.98 | $2.95 | 16.60 |
2011-09-30 | 34.85 | $3.70 | 9.41 |
2011-06-30 | 42.65 | $3.38 | 12.62 |
2011-03-31 | 39.47 | $2.57 | 15.35 |
2010-12-31 | 31.66 | $3.40 | 9.31 |
2010-09-30 | 25.58 | $1.89 | 13.53 |
2010-06-30 | 17.90 | $2.61 | 6.86 |
2010-03-31 | 20.24 | $2.35 | 8.61 |
2009-12-31 | 20.71 | $1.93 | 10.71 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $1.849B | $2.108B |
Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Veeva Systems (VEEV) | United States | $38.320B | 52.93 |
Hims & Hers Health (HIMS) | United States | $11.979B | 124.46 |
Tempus AI (TEM) | United States | $10.204B | 0.00 |
IRhythm Technologies (IRTC) | United States | $4.547B | 0.00 |
Inspire Medical Systems (INSP) | United States | $4.305B | 67.26 |
Privia Health (PRVA) | United States | $2.816B | 192.50 |
Clover Health Investments (CLOV) | United States | $1.669B | 0.00 |
Schrodinger (SDGR) | United States | $1.550B | 0.00 |
Phreesia (PHR) | United States | $1.447B | 0.00 |
Omnicell (OMCL) | United States | $1.351B | 23.83 |
Azenta (AZTA) | United States | $1.283B | 59.64 |
10x Genomics (TXG) | United States | $1.052B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.625B | 0.00 |
Butterfly Network (BFLY) | United States | $0.529B | 0.00 |
Claritev (CTEV) | United States | $0.479B | 0.00 |
Veradigm (MDRX) | United States | $0.476B | 0.00 |
Talkspace (TALK) | United States | $0.462B | 138.00 |
Standard BioTools (LAB) | United States | $0.363B | 0.00 |
TruBridge (TBRG) | United States | $0.356B | 789.67 |
Outset Medical (OM) | United States | $0.327B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.283B | 0.00 |
Health Catalyst (HCAT) | United States | $0.254B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.193B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.136B | 0.00 |
Pulmonx (LUNG) | United States | $0.126B | 0.00 |
American Well (AMWL) | United States | $0.116B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.097B | 0.00 |
CareCloud (CCLD) | United States | $0.087B | 3.31 |
111 (YI) | China | $0.067B | 0.00 |
P3 Health Partners (PIII) | United States | $0.055B | 0.00 |
HeartBeam (BEAT) | United States | $0.054B | 0.00 |
Retrieve Medical Holdings (RMHI) | United States | $0.051B | 0.00 |
Zepp Health (ZEPP) | Netherlands | $0.037B | 0.00 |
Zhongchao (ZCMD) | China | $0.029B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.022B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
Precipio (PRPO) | United States | $0.015B | 0.00 |
MSP Recovery (MSPR) | United States | $0.011B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.009B | 0.00 |
Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
Movano (MOVE) | United States | $0.004B | 0.00 |
HeartSciences (HSCS) | United States | $0.004B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
Future Health ESG (FHLT) | United States | $0.000B | 0.00 |